Sofinnova Investments, Inc. - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 106 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sofinnova Investments, Inc. ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$4,596,672
-28.7%
631,411
-20.8%
0.27%
-27.2%
Q3 2022$6,450,000
+18.8%
797,262
+247.4%
0.38%
-9.0%
Q1 2022$5,428,000
-50.3%
229,509
-62.8%
0.41%
-35.4%
Q4 2021$10,927,000
+659.3%
617,670
+1111.0%
0.64%
+650.6%
Q3 2021$1,439,00051,0060.08%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$19,415,0007.94%
TRV GP IV, LLC 2,343,154$11,481,0007.55%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 949$193,741,0002.02%
Logos Global Management LP 1,950,000$9,555,0001.75%
COWEN AND COMPANY, LLC 2,385,885$11,691,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,355,624$16,443,0000.62%
ACUTA CAPITAL PARTNERS, LLC 200,000$980,0000.55%
RTW INVESTMENTS, LP 3,961,194$19,410,0000.50%
Parkman Healthcare Partners LLC 262,689$1,287,0000.47%
Deep Track Capital, LP 1,000,000$4,900,0000.32%
View complete list of FULCRUM THERAPEUTICS INC shareholders